12:00 AM
 | 
Jan 25, 2010
 |  BC Week In Review  |  Company News  |  Deals

RXi Pharmaceuticals, UMMS deal

RXi and the university will explore the application of RXi's sd-rxRNA compounds for ocular diseases such as age-related macular degeneration...

Read the full 79 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >